- Home
- ZGN vs PRCT Comparison
ZGN vs PRCT Comparison
Compare ZGN & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZGN
- PRCT
- Stock Information
- Founded
- ZGN 1910
- PRCT 2009
- Country
- ZGN Italy
- PRCT United States
- Employees
- ZGN N/A
- PRCT N/A
- Industry
- ZGN Apparel
- PRCT Medical Specialities
- Sector
- ZGN Consumer Discretionary
- PRCT Health Care
- Exchange
- ZGN Nasdaq
- PRCT Nasdaq
- Market Cap
- ZGN 2.1B
- PRCT 2.1B
- IPO Year
- ZGN N/A
- PRCT 2021
- Fundamental
- Price
- ZGN $10.15
- PRCT $34.63
- Analyst Decision
- ZGN Buy
- PRCT Buy
- Analyst Count
- ZGN 3
- PRCT 8
- Target Price
- ZGN $9.40
- PRCT $70.00
- AVG Volume (30 Days)
- ZGN 830.1K
- PRCT 1.0M
- Earning Date
- ZGN 09-05-2025
- PRCT 10-27-2025
- Dividend Yield
- ZGN 1.38%
- PRCT N/A
- EPS Growth
- ZGN N/A
- PRCT N/A
- EPS
- ZGN 0.43
- PRCT N/A
- Revenue
- ZGN $2,248,050,499.00
- PRCT $274,950,000.00
- Revenue This Year
- ZGN N/A
- PRCT $48.38
- Revenue Next Year
- ZGN $4.69
- PRCT $30.87
- P/E Ratio
- ZGN $23.40
- PRCT N/A
- Revenue Growth
- ZGN N/A
- PRCT 55.71
- 52 Week Low
- ZGN $6.05
- PRCT $34.01
- 52 Week High
- ZGN $10.38
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- ZGN 67.65
- PRCT 36.50
- Support Level
- ZGN $8.94
- PRCT $34.01
- Resistance Level
- ZGN $10.38
- PRCT $36.48
- Average True Range (ATR)
- ZGN 0.28
- PRCT 1.58
- MACD
- ZGN 0.07
- PRCT 0.00
- Stochastic Oscillator
- ZGN 82.01
- PRCT 9.20
About ZGN Ermenegildo Zegna N.V.
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.